Purchase our respiratory diseases module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
Respiratory diseases are a concern for both pediatric and adult populations. The industrialization of developing countries will continue to increase asthma prevalence in those markets. Additionally, urban populations have increased rates of chronic pulmonary obstructive disease compared with those in rural areas. As pharmaceutical companies strive to penetrate emerging markets, respiratory disease therapies are likely to play a key role.
GlobalData's therapy module includes coverage of prevalent diseases such as asthma to niche indications such as cystic fibrosis.